Swedish Orphan Biovitrum AB

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 11.12% vs 3.34% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 50.63% vs 9.38% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,184.00",
          "val2": "6,465.00",
          "chgp": "11.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,789.00",
          "val2": "2,393.00",
          "chgp": "16.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "173.00",
          "val2": "262.00",
          "chgp": "-33.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-139.00",
          "val2": "-92.00",
          "chgp": "-51.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,318.00",
          "val2": "875.00",
          "chgp": "50.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "279.40%",
          "val2": "225.10%",
          "chgp": "5.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.50% vs 17.64% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -87.73% vs 61.02% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28,238.00",
          "val2": "26,027.00",
          "chgp": "8.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11,536.00",
          "val2": "9,538.00",
          "chgp": "20.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "813.00",
          "val2": "1,240.00",
          "chgp": "-34.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7,136.00",
          "val2": "-195.00",
          "chgp": "-3,559.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "476.00",
          "val2": "3,879.00",
          "chgp": "-87.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "285.00%",
          "val2": "223.40%",
          "chgp": "6.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

7,184.00

6,465.00

11.12%

Operating Profit (PBDIT) excl Other Income

2,789.00

2,393.00

16.55%

Interest

173.00

262.00

-33.97%

Exceptional Items

-139.00

-92.00

-51.09%

Consolidate Net Profit

1,318.00

875.00

50.63%

Operating Profit Margin (Excl OI)

279.40%

225.10%

5.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 11.12% vs 3.34% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 50.63% vs 9.38% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

28,238.00

26,027.00

8.50%

Operating Profit (PBDIT) excl Other Income

11,536.00

9,538.00

20.95%

Interest

813.00

1,240.00

-34.44%

Exceptional Items

-7,136.00

-195.00

-3,559.49%

Consolidate Net Profit

476.00

3,879.00

-87.73%

Operating Profit Margin (Excl OI)

285.00%

223.40%

6.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 8.50% vs 17.64% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -87.73% vs 61.02% in Dec 2024

All Annual Results